Thanks for emailing that article!
Glaucoma Research Foundation’s Annual Gala kicked off the 7th Annual Glaucoma 360 on February 8th at the historic Palace Hotel in San Francisco. This annual fundraising event, co-chaired by Mona and Edward Zander, honors visionary leaders and volunteers committed to making a difference in the lives of people with glaucoma.
The special evening included presentation of the Catalyst Award to Thomas W. Burns, President and CEO of Glaukos Corporation, in recognition of his exemplary leadership and commitment to glaucoma innovation. Carl V. Migliazzo, MD received the President’s Award in honor of his outstanding partnership and involvement in our patient education programs. The audience celebrated the announcement of a $1.5 million gift made in honor of Dr. Migliazzo, from Liz Stratton to support The Cure is in Sight Campaign. This contribution represents the largest single gift from a living donor and will allow Glaucoma Research Foundation to launch our next major collaborative research initiative.
The 2018 Shaffer Prize for Innovative Glaucoma Research was awarded to Carla J. Siegfried, MD from Washington University, to recognize her exceptional research project funded through a Shaffer Grant in 2016.
The Gala Auction Chair, Amanda Eddy, introduced a matching challenge for the Fund-A-Scientist initiative and shared her struggle living with glaucoma: “Tonight’s event and the funds raised go toward finding a cure for glaucoma — something I know will be achieved in my lifetime.”
Thanks to matching funds from the Edward Joseph Daly Foundation, Elizabeth and James B. Wise, MD, and Sharma and Paul Schacknow, MD, PhD, as well as generous support from Gala attendees, more than $550,000 was raised to support Glaucoma Research Foundation’s research and education programs.
The following day, February 9th, more than 50 companies and institutions were featured during a full day of presentations and panel discussions highlighting innovations in glaucoma with leaders from start-up companies, industry executives, ophthalmic experts, venture capitalists, and the FDA. One special focus of this year’s Forum was the use of virtual reality (VR) in glaucoma care, with presentations on the use of VR in research and product development.
Iqbal Ike K. Ahmed, MD, Medical Director, Prism Eye Institute, Assistant Professor at the University of Toronto, and Clinical Professor at the University of Utah, delivered the Drs. Henry and Frederick Sutro Memorial Lecture, the Forum’s keynote address. His topic, “Interventional Glaucoma: The Why, The Who, and The How,” emphasized the importance of a proactive approach to glaucoma, and preventing problems before they arise.
He noted that the advent of micro-invasive glaucoma surgery (MIGS) is providing doctors with new opportunities to control primary open-angle glaucoma with earlier intervention.
The New Horizons Forum, now in its 7th year, has become an important glaucoma innovation meeting, providing a unique platform to highlight and advance new diagnostics and treatments to help patients now and in the future.
The third and final day of Glaucoma 360 focused on continuing education for practicing ophthalmologists and optometrists. Sessions led by prominent leaders in eye care highlighted the latest advances in glaucoma, with information about medications, diagnostic challenges, and surgical technique. Alan S. Crandall, MD, from the John A. Moran Eye Center at the University of Utah, presented the Shaffer-Hetherington-Hoskins Lecture on the topic of treating glaucoma combined with cataracts.
We are grateful to our donors, volunteers, speakers, and attendees for their outstanding support and involvement. Next year's Glaucoma 360 events will be held from January 31 to February 2, 2019 in San Francisco.
Last reviewed on May 01, 2018
This article appeared in the May 2018 issue of Gleams.Subscribe